Cas No. 86639-52-3, 7-Ethyl-10-hydroxycamptothecin

Irinotecan, a topoisomerase inhibitor, plays a pivotal role in combating various solid tumors, including colorectal, lung, and pancreatic cancers. Our reliable intermediates ensure a smooth manufacturing process, guaranteeing a steady supply of this life-saving medication. Join forces with us to transform cancer treatment, offering patients renewed hope and improved outcomes. Discover the potential of Irinotecan and make a significant impact in the fight against cancer.